INR 113.15
(0.85%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 253.82 Million INR | -18.34% |
2022 | 310.82 Million INR | 38.41% |
2021 | 224.56 Million INR | 91.72% |
2020 | 117.13 Million INR | 201.53% |
2019 | 38.84 Million INR | -82.67% |
2018 | 224.12 Million INR | -11.15% |
2017 | 252.25 Million INR | 43.0% |
2016 | 176.39 Million INR | 49.75% |
2015 | 117.79 Million INR | -24.3% |
2014 | 155.59 Million INR | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q1 | 30.94 Million INR | -73.65% |
2023 Q2 | 52.38 Million INR | 551.43% |
2023 FY | 253.82 Million INR | -18.34% |
2023 Q1 | 8.04 Million INR | -92.36% |
2023 Q3 | 75.97 Million INR | 45.03% |
2023 Q4 | 117.42 Million INR | 54.54% |
2022 Q4 | 105.19 Million INR | 14.4% |
2022 Q1 | 69.12 Million INR | -34.63% |
2022 Q2 | 78.9 Million INR | 14.14% |
2022 FY | 310.82 Million INR | 38.41% |
2022 Q3 | 91.94 Million INR | 16.53% |
2021 Q4 | 105.75 Million INR | 54.4% |
2021 FY | 224.56 Million INR | 91.72% |
2021 Q1 | 16.11 Million INR | -66.24% |
2021 Q3 | 68.49 Million INR | 1.03% |
2021 Q2 | 67.79 Million INR | 320.72% |
2020 Q2 | 90.45 Million INR | 23.34% |
2020 Q3 | 43.32 Million INR | -52.1% |
2020 FY | 117.13 Million INR | 201.53% |
2020 Q4 | 47.72 Million INR | 10.14% |
2020 Q1 | 73.33 Million INR | 76.26% |
2019 Q1 | 8.05 Million INR | -88.24% |
2019 Q2 | 15.57 Million INR | 93.37% |
2019 FY | 38.84 Million INR | -82.67% |
2019 Q4 | 41.6 Million INR | -14.68% |
2019 Q3 | 48.76 Million INR | 213.2% |
2018 Q4 | 68.47 Million INR | -35.29% |
2018 Q2 | 76.77 Million INR | 16.58% |
2018 Q1 | 65.85 Million INR | -30.96% |
2018 FY | 224.12 Million INR | -11.15% |
2018 Q3 | 105.8 Million INR | 37.81% |
2017 Q4 | 95.38 Million INR | 9.99% |
2017 Q3 | 86.72 Million INR | 23.81% |
2017 Q1 | 46.7 Million INR | 0.0% |
2017 Q2 | 70.04 Million INR | 49.98% |
2017 FY | 252.25 Million INR | 43.0% |
2016 FY | 176.39 Million INR | 49.75% |
2015 FY | 117.79 Million INR | -24.3% |
2014 FY | 155.59 Million INR | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Ajanta Pharma Limited | 19.67 Billion INR | 98.71% |
Amrutanjan Health Care Limited | 457.54 Million INR | 44.524% |
Sigachi Industries Limited | 1.47 Billion INR | 82.778% |
Bal Pharma Limited | 233.9 Million INR | -8.516% |
Ind-Swift Laboratories Limited | 4.42 Billion INR | 94.258% |
Medico Remedies Limited | 100.3 Million INR | -153.07% |
Lasa Supergenerics Limited | -458 Million INR | 155.421% |
Venus Remedies Limited | 534.65 Million INR | 52.524% |
Sun Pharma Advanced Research Company Limited | -4.11 Billion INR | 106.168% |
Alpa Laboratories Limited | 184.49 Million INR | -37.579% |
Nectar Lifesciences Limited | 923.8 Million INR | 72.524% |
Shilpa Medicare Limited | 1.36 Billion INR | 81.422% |
Aarti Drugs Limited | 7.14 Billion INR | 96.449% |
Lupin Limited | 28.04 Billion INR | 99.095% |
Aurobindo Pharma Limited | 42.2 Billion INR | 99.399% |
Zydus Lifesciences Limited | 43.1 Billion INR | 99.411% |
Windlas Biotech Limited | 1.29 Billion INR | 80.458% |
Suven Life Sciences Limited | -1.22 Billion INR | 120.707% |
Eris Lifesciences Limited | 5.18 Billion INR | 95.101% |
Valiant Laboratories Limited | - INR | -Infinity% |
J. B. Chemicals & Pharmaceuticals Limited | 14.28 Billion INR | 98.223% |
Solara Active Pharma Sciences Limited | -3.85 Billion INR | 106.588% |
Ipca Laboratories Limited | 7.98 Billion INR | 96.819% |
Bliss GVS Pharma Limited | 1.23 Billion INR | 79.38% |
Achyut Healthcare Limited | 4.43 Million INR | -5619.446% |
Sun Pharmaceutical Industries Limited | 104.3 Billion INR | 99.757% |
Bajaj HealthCare Limited | - INR | -Infinity% |
RPG Life Sciences Limited | 2.29 Billion INR | 88.927% |
Mankind Pharma Limited | 21.51 Billion INR | 98.82% |
Laurus Labs Limited | 3.94 Billion INR | 93.572% |
Piramal Pharma Limited | 4.55 Billion INR | 94.43% |
Syncom Formulations (India) Limited | 249.25 Million INR | -1.837% |
Torrent Pharmaceuticals Limited | 25.33 Billion INR | 98.998% |
Alembic Pharmaceuticals Limited | 5.75 Billion INR | 95.592% |
Glenmark Pharmaceuticals Limited | 6.5 Billion INR | 96.096% |
Unichem Laboratories Limited | - INR | -Infinity% |
Sequent Scientific Limited | - INR | -Infinity% |
Novartis India Limited | 626.5 Million INR | 59.485% |
Wanbury Limited | 569.71 Million INR | 55.446% |
Suven Pharmaceuticals Limited | 4.6 Billion INR | 94.491% |
Wockhardt Limited | -670 Million INR | 137.885% |
Themis Medicare Limited | 392.58 Million INR | 35.345% |
Jagsonpal Pharmaceuticals Limited | 508.13 Million INR | 50.046% |
Jubilant Pharmova Limited | 5.18 Billion INR | 95.108% |
Glenmark Life Sciences Limited | 8.97 Billion INR | 97.173% |
Dr. Reddy's Laboratories Limited | 67.72 Billion INR | 99.625% |
Divi's Laboratories Limited | 33.08 Billion INR | 99.233% |
NATCO Pharma Limited | 25.96 Billion INR | 99.022% |
Gufic Biosciences Limited | 1.32 Billion INR | 80.914% |
IOL Chemicals and Pharmaceuticals Limited | 1.59 Billion INR | 84.104% |
Ind-Swift Limited | 1.22 Billion INR | 79.296% |
Procter & Gamble Health Limited | 2.78 Billion INR | 90.889% |
FDC Limited | 2.98 Billion INR | 91.5% |
Krebs Biochemicals & Industries Limited | -151.95 Million INR | 267.04% |
Granules India Limited | 6.81 Billion INR | 96.276% |
Medicamen Biotech Limited | - INR | -Infinity% |
Alkem Laboratories Limited | 19.46 Billion INR | 98.696% |
AstraZeneca Pharma India Limited | 1.71 Billion INR | 85.221% |
Biofil Chemicals and Pharmaceuticals Limited | 9.06 Million INR | -2698.957% |
Brooks Laboratories Limited | 14.44 Million INR | -1657.819% |
Megasoft Limited | -121.1 Million INR | 309.596% |
Strides Pharma Science Limited | 5.22 Billion INR | 95.143% |
Neuland Laboratories Limited | 5.31 Billion INR | 95.227% |
Morepen Laboratories Limited | 4.17 Billion INR | 93.919% |
Hikal Limited | 32.11 Million INR | -690.498% |
Indoco Remedies Limited | 1.29 Billion INR | 80.362% |
Aarti Pharmalabs Limited | 3.12 Billion INR | 91.886% |
Kilitch Drugs (India) Limited | 208.05 Million INR | -22.004% |
Mangalam Drugs & Organics Limited | 27.45 Million INR | -824.426% |
Hester Biosciences Limited | 364.81 Million INR | 30.422% |